Development of a monoclonal antibody-based enzyme-linked immunoabsorbent assay for the binding of gp130 to the IL-6/IL-6R complex and its competitive inhibition

Journal of Immunological Methods

Volumn 291, Issue 1-2, 2004, Pages 93-100

  Scheller, Jürgen ^a   Kovaleva, Marina ^a   Rabe, Björn ^a   Eichler, Jutta ^b   Kallen, Karl Josef ^c   Rose John, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c MERCK KGAA   (Germany)

Author keywords

ELISA; enzyme linked immunoabsorbent assay; gp130; Hyper IL 6; IL 6; IL 6R; interleukin 6; interleukin 6 receptor; sIL 6R; soluble interleukin 6 receptor; vIL 6; viral IL 6

Indexed keywords

CHEMICAL COMPOUND; GLYCOPROTEIN GP 130; HYBRID PROTEIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MONOCLONAL ANTIBODY; SURAMIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SCREENING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BINDING, COMPETITIVE; CELL LINE; CYTOKINE RECEPTOR GP130; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-6; MACROMOLECULAR SUBSTANCES; MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-6;

EID: 4444273088     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.05.002     Document Type: Article

References (38)

1. Atreya R., Mudter J., Finotto S., Müllberg J., Jostock T., Wirtz S., Schütz M., Bartsch B., Holtmann M., Becker C., Strand D., Czaja J., Schlaak J.F., Lehr H.A., Autschbach F., Schürmann G., Nishimoto N., Yoshizaki K., Ito H., Kishimoto T., Galle P.R., Rose-John S., Neurath M.F. Blockade of IL-6 transsignaling abrogates established experimental colitis in mice by suppression of the antiapoptotic resistance of lamina propria T cells. Nat. Med. 6:2000;583
2. Baumann H., Strassmann G. Suramin inhibits the stimulation of acute phase plasma protein genes by IL-6-type cytokines in rat hepatoma cells. J. Immunol. 151:1993;1456
3. Beck J.T., Hsu S.M., Wijdenes J., Bataille R., Klein B., Vesole D., Hayden K., Jagannath S., Barlogie B. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N. Engl. J. Med. 330:1994;602
4. Brakenhoff J.P., Hart M., De Groot E.R., Di Padova F., Aarden L.A. Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants. J. Immunol. 145:1990;561
5. Choy E.H., Isenberg D.A., Garrood T., Farrow S., Ioannou Y., Bird H., Cheung N., Williams B., Hazleman B., Price R., Yoshizaki K., Nishimoto N., Kishimoto T., Panayi G.S. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum. 46:2002;3143
6. Desgeorges A., Gabay C., Silacci P., Novick D., Roux-Lombard P., Grau G., Dayer J.M., Vischer T., Guerne P.A. Concentrations and origins of soluble interleukin-6 receptor-alpha in serum and synovial fluid. J. Rheumatol. 24:1997;1510
7. Durocher Y., Perret S., Kamen A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 30:2002;2002
8. Fischer M., Goldschmitt J., Peschel C., Kallen K.J., Brakenhoff J.P.J., Wollmer A., Grötzinger J., Rose-John S. A designer cytokine with high activity on human hematopoietic progenitor cells. Nat. Biotechnol. 15:1997;142
9. Grötzinger J., Kurapkat G., Wollmer A., Kalai M., Rose-John S. The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes. Prot. Struct. Funct. Genet. 27:1997;96
10. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374:2003;1
11. Hoischen S.H., Vollmer P., März P., Özbek S., Götze K., Jostock T., Geib T., Müllberg J., Mechtersheimer S., Fischer M., Grötzinger J., Galle P.R., Rose-John S. Human herpesvirus 8 interleukin-6 homologue triggers gp130 on neuronal and hematopoietic cells. Eur. J. Biochem. 267:2000;3604
12. Hurst S.M., Wilkinson T.S., McLoughlin R.M., Jones S., Horiuchi S., Yamamoto N., Rose-John S., Fuller G.M., Topley N., Jones S.A. Control of leukocyte infiltration during inflammation: IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment. Immunity. 14:2001;705
13. Imazeki I., Saito H., Hasegawa M., Shinkura H., Kishimoto T., Ohsugi Y. IL-6 functions in cynomolgus monkeys blocked by a humanized antibody to human IL-6 receptor. Int. J. Immunopharmacol. 20:1998;345
14. Ito H. IL-6 and Crohn's disease. Curr. Drug Targets Inflamm. Allergy. 2:2003;125
15. Jones S.A., Novick D., Horiuchi S., Yamamoto N., Szalai A.J., Fuller G.M. C-reactive protein: a physiological activator of interleukin 6 receptor shedding. J. Exp. Med. 189:1999;599
16. Jostock T., Blinn G., Renné C., Kallen K.-J., Rose-John S., Müllberg J. Immunoadhesins of IL-6 and hyper IL-6. J. Immunol. Methods. 223:1999;171
17. Jostock T., Müllberg J., Özbek S., Atreya R., Blinn G., Voltz N., Fischer M., Neurath M.F., Rose-John S. Soluble gp130 is the natural inhibitor of soluble IL-6R transsignaling responses. Eur. J. Biochem. 268:2001;160
18. Kallen K.-J. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochem. Biophys. Acta. 1592:2002;323
19. Keul R., Heinrich P.C., Muller-Newen G., Muller K., Woo P. A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis. Cytokine. 10:1998;729
20. Liautard J., Gaillard J.P., Mani J.C., Montero Julian F., Duperray C., Lu Z.Y., Jourdan M., Klein B., Brailly H., Brochier J. Epitope analysis of human IL-6 receptor gp80 molecule with monoclonal antibodies. Eur. Cytokine Netw. 5:1994;293
21. Lust J.A., Donovan K.A., Kline M.P., Greipp P.R., Kyle R.A., Maihle N.J. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine. 4:1992;96
22. Mackiewicz A., Schooltink H., Heinrich P.C., Rose-John S. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J. Immunol. 149:1992;2021
23. Madhok R., Crilly A., Watson J., Capell H.A. Serum interleukin-6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann. Rheum. Dis. 52:1993;232
24. Mihara M., Kotoh M., Nishimoto N., Oda Y., Kumagai E., Takagi N., Tsunemi K., Ohsugi Y., Kishimoto T., Yoshizaki K., Takeda Y. Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys. Clin. Immunol. 98:2001;319
25. Montero Julian F.A., Liautard J., Flavetta S., Romagne F., Gaillard J.P., Brochier J., Klein B., Brailly H. Immunoassay for functional human soluble interleukin-6 receptor in plasma based on ligand/receptor interactions. J. Immunol. Methods. 169:1994;111
26. Müllberg J., Schooltink H., Stoyan T., Heinrich P.C., Rose-John S. Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor. Biochem. Biophys. Res. Commun. 189:1992;794
27. Müllberg J., Geib T., Jostock T., Hoischen S.H., Vollmer P., Voltz N., Heinz D., Galle P.R., Klouche M., Rose-John S. IL-6-receptor independent stimulation of human gp130 by viral IL-6. J. Immunol. 164:2000;4672
28. Ng D.C., Bogoyevitch M.A. The mechanism of heat shock activation of ERK mitogen-activated protein kinases in the interleukin 3-dependent ProB cell line BaF3. J. Biol. Chem. 275:2000;40856
29. Nowell M.A., Richards P.J., Horiuchi S., Yamamoto N., Rose-John S., Topley N., Williams A.S., Jones S.A. Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. J. Immunol. 171:2003;3202
30. Peters M., Müller A., Rose-John S. Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Blood. 92:1998;3495
31. Rose-John S., Heinrich P.C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300:1994;281
32. Strassmann G., Fong M., Freter C.E., Windsor S., D'Alessandro F., Nordan R.P. Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo. J. Clin. Invest. 92:1993;2152
33. Taga T., Kishimoto T. Signaling mechanisms through cytokine receptors that share signal transducing receptor components. Curr. Opin. Immunol. 7:1995;17
34. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 58:1989;573
35. Takagi M., Mihara M., Moriya Y., Nishimoto N., Yoshizaki K., Kishimoto T., Takeda Y., Ohsugi Y. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum. 41:1998;2117
36. Vollmer P., Oppmann B., Voltz N., Fischer M., Rose-John S. A role for the immunoglobulin-like domain of the human IL-6 receptor: intracellular protein transport and shedding. Eur. J. Biochem. 263:1999;438
37. Wendling D., Racadot E., Wijdenes J. Treatment of severe rheumatoid arthritis by anti-interleukin-6 monoclonal antibody. J. Rheumatol. 20:1993;259
38. Yasukawa K., Futatsugi K., Saito T., Yawata H., Narazaki M., Suzuki H., Taga T., Kishimoto T. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. Immunol. Lett. 31:1992;123